Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-melanoma immunoscintigraphy]

A I Santos1, F Godinho

  • 1Instituto de Medicina Nuclear, Faculdade de Medicina de Lisboa, Hospital de Santa Maria.

Acta Medica Portuguesa
|January 1, 1995
PubMed
Summary

Immunoscintigraphy using antibody 225.28S shows high accuracy in detecting melanoma. This nuclear medicine technique aids in diagnosing skin and uveal melanoma metastases and primary lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exertional chest pain is sometimes more than just coronary atherosclerosis.

Revista portuguesa de cardiologia·2021
Same author

Post-stroke psychosis with atypical features.

L'Encephale·2020
Same author

Assessment of the Absorbed Dose in the Kidney of Nuclear Nephrology Paediatric Patients using ICRP Biokinetic Data and Monte Carlo Simulations with Mass-Scaled Paediatric Voxel Phantoms.

Radiation protection dosimetry·2016
Same author

Pulmonary ventilation/perfusion single photon emission tomography--Initial experience of a Nuclear Medicine Department.

Revista portuguesa de pneumologia·2015
Same author

S-nitrosation and neuronal plasticity.

British journal of pharmacology·2014
Same author

Estimation of the collective ionizing dose in the Portuguese population for the years 2011 and 2012, due to nuclear medicine exams.

Revista espanola de medicina nuclear e imagen molecular·2014

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Immunology

Background:

  • Nuclear Medicine aids oncologic disease study.
  • Immunoscintigraphy evaluates biodistribution of radiolabeled antibodies against tumor antigens.
  • First used for skin malignant melanoma in 1983.

Purpose of the Study:

  • Evaluate the clinical utility of immunoscintigraphy in diagnosing skin and uveal melanoma.
  • Assess the accuracy of immunoscintigraphy in detecting melanoma metastases and primary lesions.

Main Methods:

  • Utilized antibody 225.28S (IgG2a) targeting a melanoma antigen.
  • Performed 67 immunoscintigraphy exams between 1992-1994 (44 skin, 23 uveal melanoma).
  • Calculated true positive and true negative rates for both melanoma types.

Main Results:

  • Achieved 87.5% true positive and 90% true negative rates for skin melanoma.
  • Achieved 94% true positive and 83% true negative rates for uveal melanoma.
  • Demonstrated effectiveness in detecting loco-regional and distant skin melanoma metastases and aiding differential diagnosis.

Conclusions:

  • Immunoscintigraphy is valuable for staging skin melanoma, identifying unsuspected metastases, and differential diagnosis.
  • Immunoscintigraphy may assist in evaluating primary uveal melanoma and differentiating it from other intra-ocular lesions.

Related Experiment Videos